[Clinical data on the use of selenase in sepsis].
Lehmann
Ch
Ch
Klinik und Poliklinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Greifswald (AöR), Ernst-Moritz-Arndt-Universität Greifswald, Greifswald. Christian.Lehmann@uni-greifswald.de
D000975:Antioxidants / Q000627:therapeutic use*; D002478:Cells, Cultured; D006305:Health Status Indicators; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D007362:Intensive Care Units; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D017382:Reactive Oxygen Species / Q000097:blood; D012643:Selenium / Q000097:blood*; D018805:Sepsis / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D018038:Sodium Selenite / Q000627:therapeutic use*; D015996:Survival Rate; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000188:drug therapy* / Q000401:mortality
D000975:Antioxidants; D018836:Inflammation Mediators; D017382:Reactive Oxygen Species; D012643:Selenium; D018038:Sodium Selenite